Back to results
US 2026/0272468 A1Published application
Sustained Release Liposomal Pharmaceutical Embolizing Agents for Treating Chronic Subdural Hematoma, Intractable Migraines, Headaches, and Other Pain Conditions
AssigneeMG Stroke Analytics Inc.
InventorMayank Goyal
Life of this patent
Estimating the term…
Abstract
Pharmaceutical embolizing agents and methods of use thereof to treat pain and other conditions include a medical gel mixed with a radiopaque compound and a sustained release treatment drug compound. The pharmaceutical embolizing agent is injected into a patient through a catheter in order to form an embolus in the patient's vessel, such as the middle meningeal artery, and slowly release the treatment drug over time without being moved or displaced.
Claims20
A method of treating pain in a patient, the method comprising:
- forming a vascular access into the patient;
- advancing a catheter through the patient's vasculature to a target artery supplying blood to a pain-associated anatomical region;
- and
- administering through the catheter a pharmaceutical embolizing agent to a location in said target artery, wherein the pharmaceutical embolizing agent comprises an injectable biocompatible medical gel and a sustained-release analgesic incorporated within the medical gel, wherein the pharmaceutical embolizing agent is adapted to (i) form an embolus at said location, (ii) release a therapeutic drug at said location over time, and (iii) be structurally stabilized at the location to retain the analgesic without migration within the target artery and release the analgesic over an extended period to reduce pain experienced by the patient.
1 more element
Dependencies are inferred from the claim text.